• Novel neurosteroid therapeutics for post-partum depression: perspectives on clinical trials, program development, active research, and future directions
  Published on 2023-09-15
  2 years ago
• Decreased CNNM2 expression in prefrontal cortex affects sensorimotor gating function, cognition, dendritic spine morphogenesis and risk of schizophrenia
  Published on 2023-09-15
  2 years ago
• Modulators of GABAA receptor-mediated inhibition in the treatment of neuropsychiatric disorders: past, present, and future
  Published on 2023-09-14
  2 years ago
• Practical recommendations to improve retention of underrepresented minorities in science and medicine: an early career perspective
  Published on 2023-09-11
  2 years ago
• Comment on: Effects of selective dopamine D3 receptor partial agonist/antagonists on oxycodone self-administration and antinociception in monkeys
  Published on 2023-09-08
  2 years ago
• Leucine-rich repeat kinase 2 limits dopamine D1 receptor signaling in striatum and biases against heavy persistent alcohol drinking
  Published on 2023-09-08
  2 years ago
• G protein-biased LPAR1 agonism of prototypic antidepressants: Implication in the identification of novel therapeutic target for depression
  Published on 2023-09-06
  2 years ago

« Previous 1 … 80 81 82 83 84 … 143 Next »

• A prospective study to determine the clinical utility of pharmacogenetic testing of veterans with treatment-resistant depression
  Published on 2021-05-03
  5 years ago
• Effect of medication on risk of traumatic brain injury in patients with bipolar disorder: A nationwide population-based cohort study
  Published on 2021-05-03
  5 years ago
• Equasy revisited
  Published on 2021-05-03
  5 years ago
• The biologically active compound of Withania somnifera (L.) Dunal, docosanyl ferulate, is endowed with potent anxiolytic properties but devoid of typical benzodiazepine-like side effects
  Published on 2021-05-03
  5 years ago
• Selective attention to emotional stimuli and emotion recognition in patients with major depression: The role of mineralocorticoid and glutamatergic NMDA receptors
  Published on 2021-04-28
  5 years ago
• Discontinuation and relapse with paliperidone palmitate three-monthly for maintenance of schizophrenia: Two year follow-up of use in clinical practice
  Published on 2021-04-28
  5 years ago
• Easier patient access to medical cannabis carries risks as well as benefits
  Published on 2021-04-28
  5 years ago

« Previous 1 … 80 81 82 83 84 … 134 Next »

• Exploring the relationship between the gut microbiome and mental health outcomes in a posttraumatic stress disorder cohort relative to trauma-exposed controls
  Published on 2021-12-17
  4 years ago
• COVID-19 and Behavioral Addictions: Worrying consequences?
  Published on 2021-12-17
  4 years ago
• Null effect of vortioxetine augmentation with celecoxib should not be generalized to other antidepressants – Author’s reply
  Published on 2021-12-06
  4 years ago
• Selective association of cytokine levels and kynurenine/tryptophan ratio with alterations in white matter microstructure in bipolar but not in unipolar depression
  Published on 2021-11-28
  4 years ago
• A meta-analysis of polygenic risk scores for mood disorders, neuroticism, and schizophrenia in antidepressant response
  Published on 2021-11-27
  4 years ago
• Emotional cognition in depression: Is it relevant for Clinical practice?
  Published on 2021-11-26
  4 years ago
• Null effect of vortioxetine augmentation with celecoxib should not be generalized to other antidepressants
  Published on 2021-11-24
  4 years ago

« Previous 1 … 80 81 82 83 84 … 154 Next »